It refers to the pharmacological component, which is characterized by containing at least one new virus-resistant cucumber or its pharmacologically acceptable salt, a pH modifier and a carrier； among them, at least one new virus-resistant cucumber consists of PI ≥ 5 and hydro ≥ 6.0, PI ≥ 8 and hydro ≥ 8.0, PI ≥ 5 and hydro ≥ 5, PI ≥ 9, e, hydro ≤ 8.0, or PI e≥5.5. GT；7 e Hydro≥5.5。 It also refers to a method of preparing vaccine formulations or immune components for the treatment or prevention of tumors.Referido a una composicion farmaceutica caracterizada porque comprende al menos un peptido neo-antigeno o su sal farmaceuticamente aceptable, un modificador de pH y un portador； en donde al menos un peptido neo-antigeno es determinado por Pi ≥ 5 e HYDRO ≥ -6.0, Pi ≥ 8 e HYDRO ≥ -8.0, Pi ≤ 5 e HYDRO ≥ -5, Pi ≥ 9 e HYDRO ≤ -8.0, o Pi >； 7 e HYDRO ≥ -5.5. Tambien se refiere a un metodo para preparar la formulacion para composicion de vacuna o composicion inmunogena para el tratamiento o prevencion de neoplasias.
